Goldman Sachs is likely to convert some of its loan to online pharmacy PharmEasy into equity. Buoyed by binding commitments from existing investors, the epharnacy also plans to pay back a considerable chunk of its debt following the rights issue in September. This and more in todays ETtech Morning Dispatch.